The travesty around the data faking regenerative medicine enthusiast Suchitra Sumitran-Holgersson is finally over. Her Swedish employer University of Gotheburg (GU) announced yesterday to have opened labour law proceedings against her, with the expressed goal of her dismissal as university professor. No appeal is possible anymore, and her loyal GU supporters Elias Eriksson and Kristoffer Hellstrand can now take a rest from nearly 10 years of lobbying, obstructing and bullying everyone involved in the misconduct investigations of their dear colleague. On top, retractions of 7 Sumitran-Holgersson publications were requested by the GU rector.
Sumitran-Holgersson, formerly a Karolinska Institutet researcher, survived a misconduct investigation by the Swedish Research Council from 2009-2011, because her friends achieved a dismissal of all damning evidence of data manipulation on formality grounds; the two investigators themselves ended up threatened with lawsuits. The newly appointed GU professor only had to retract one paper. In early 2016, when the regenerative medicine scandal around Paolo Macchiarini exploded in Sweden, PubPeer evidence of image manipulations was posted en masse (including by certain readers of my site) about Sumitran-Holgersson’s work in the field. That prompted a new misconduct investigation by GU and the Swedish Central Ethics Review Board (CEPN). In spring 2016, Sumitran-Holgersson saw her funding frozen and her paper retracted, which reported an unethical Macchiarini-style trachea transplant, likely responsible for the death of that patient. That work was performed together with GU surgeon Michael Olausson, with whom Sumitran-Holgersson also developed bioengineered blood vessels which they tested on children without proper ethics approvals. For that, both were found guilty of misconduct one year later, in March 2017. Which not only still didn’t cost Sumitran-Holgersson her job as GU professor: her own business Verigraft was right after awarded €2.3 mn by the EU Commission under Horizon 2020, based on her papers tainted with data manipulations and severe ethics breaches. The money was earmarked by excited EU bureaucrats to market and bring that very same blood vessel graft technology into a large clinical trial; in this regard please read the excellent investigation for my site by Sophia Tibblin. Olausson’s own misconduct activities in the area of regenerative medicine and especially trachea transplantation served as his qualification to advice the Swedish State Prosecutor to drop manslaughter charges against Macchiarini in October 2017.
In March 2018, both Sumitran-Holgersson and Olausson were found guilty of misconduct once again, this time it was about data manipulation flagged on PubPeer 2 years before. Retractions of 8 papers was recommended by the CEPN decision, which GU now largely upheld in the rector’s yesterday’s announcement, with the difference that now all co-authors were freed of suspicions of misconduct. Update 7.07.2018: That was because GU’s (now updated) good scientific practice rules of the time did not sanction negligence, of which Michael Olausson and Jan Holgersson (Suchitra’s husband, also professor at GU and Chairman of Verigraft) were found guilty of, but with no disciplinary consequences.
For the indestructible Sumitran-Holgersson though it is now the end of the road. Continue reading “Gothenburg to sack Sumitran-Holgersson, requests 7 retractions”